Grifols, S.A.

Healthcare · Drug Manufacturers - General · Spain

Last price 8.1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.30B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as wel...